Investments
40Portfolio Exits
3Funds
4Partners & Customers
1About TriVentures
Triventures is a venture capital fund focused on investing in medical device and digital health technologies from seed stage to industry leaders. The firm has over $100 million under management dedicated to ventures primarily in Israel and the U.S.
TriVentures Headquarter Location
11 Hasadnaot St. Sea View Building #B, 5th Floor
Herzliya, 4673300,
Israel
+972-9-779-3800
Latest TriVentures News
Mar 29, 2022
Brightside Health , a San Francisco, CA-based telemedicine platform that offers fast access to personalized treatment, expert providers, and ongoing support for a range of mental health concerns, raised $50m in Series B funding. The round, which brought total funding to date to $75m, was led by ACME Capital and Mousse Partners, with participation from existing investors Bullpen Capital, Triventures, and Trousdale Ventures. Led by Brad Kittredge, founder and CEO, Brightside Health is a telemedicine platform focused on developing and delivering a new standard of mental health care. By pairing empathy and expertise with innovative technology, the company provides a personalized treatment experience for every member through video visits, unlimited messaging, ongoing support, and medication delivery. Its care model encompasses precision-psychiatry, a clinically-proven approach to therapy, and continuous care monitoring from a network of providers. Brightside Health treats the full spectrum of symptom severity, including people with complex conditions, and offers timely appointments from home, available in as little as 24 hours. With convenient access to treatment through video visits, unlimited messaging, ongoing support, and medication delivery, Brightside Health helps people feel better faster, and stay that way longer. The platform adheres to evidence-based approaches, guided by a world-class network of psychiatric providers and licensed therapists who utilize innovative support tools and follow structured, clinically-proven protocols to deliver effective care at scale. Members track progress through online check-ins that are also monitored by providers, ensuring the efficacy of personalized treatment plans and enabling rapid intervention should a need arise. FinSMEs
TriVentures Investments
40 Investments
TriVentures has made 40 investments. Their latest investment was in Future Family as part of their Series B on April 4, 2022.
TriVentures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
4/5/2022 | Series B | Future Family | $25M | Yes | 2 | |
12/13/2021 | Seed VC - II | Lynx.MD | $12M | No | Amdocs Ventures, iAngels, MizMaa Ventures, New York Life Ventures, Undisclosed Angel Investors, and UpWest | 2 |
12/8/2021 | Series B | Brightside | $50M | Yes | 2 | |
6/9/2021 | Seed VC | |||||
6/7/2021 | Series B |
Date | 4/5/2022 | 12/13/2021 | 12/8/2021 | 6/9/2021 | 6/7/2021 |
---|---|---|---|---|---|
Round | Series B | Seed VC - II | Series B | Seed VC | Series B |
Company | Future Family | Lynx.MD | Brightside | ||
Amount | $25M | $12M | $50M | ||
New? | Yes | No | Yes | ||
Co-Investors | Amdocs Ventures, iAngels, MizMaa Ventures, New York Life Ventures, Undisclosed Angel Investors, and UpWest | ||||
Sources | 2 | 2 | 2 |
TriVentures Portfolio Exits
3 Portfolio Exits
TriVentures has 3 portfolio exits. Their latest portfolio exit was Cardiva Medical on January 20, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
1/20/2021 | Acquired | 5 | |||
Date | 1/20/2021 | ||
---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 5 |
TriVentures Fund History
4 Fund Histories
TriVentures has 4 funds, including Triventures ARC.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/18/2019 | Triventures ARC | $40M | 2 | ||
5/18/2015 | TriVentures III | ||||
12/31/2009 | TriVentures II Fund LP | ||||
Triventures ARC Fund |
Closing Date | 9/18/2019 | 5/18/2015 | 12/31/2009 | |
---|---|---|---|---|
Fund | Triventures ARC | TriVentures III | TriVentures II Fund LP | Triventures ARC Fund |
Fund Type | ||||
Status | ||||
Amount | $40M | |||
Sources | 2 |
TriVentures Partners & Customers
1 Partners and customers
TriVentures has 1 strategic partners and customers. TriVentures recently partnered with Genoox on May 5, 2018.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
5/15/2018 | Partner | United States | Triventures, Leading Healthcare Investor, Backs Genoox in $6 Million Funding Round `` We are excited to kick off this partnership with Triventures , as we continue growing in the U.S. and addressing demand for streamlined , clinical genomics applications , '' said Amir Trabelsi , co-founder and CEO of Genoox . | 4 |
Date | 5/15/2018 |
---|---|
Type | Partner |
Business Partner | |
Country | United States |
News Snippet | Triventures, Leading Healthcare Investor, Backs Genoox in $6 Million Funding Round `` We are excited to kick off this partnership with Triventures , as we continue growing in the U.S. and addressing demand for streamlined , clinical genomics applications , '' said Amir Trabelsi , co-founder and CEO of Genoox . |
Sources | 4 |
TriVentures Team
5 Team Members
TriVentures has 5 team members, including current Founder, Managing Partner, Michal Geva.
Name | Work History | Title | Status |
---|---|---|---|
Peter J. Fitzgerald | Founder | Current | |
Michal Geva | Founder, Managing Partner | Current | |
Martin B Leon | Founder | Current | |
Dani Goldsher | LR Group, and Deloitte | Chief Financial Officer | Current |
Netalie Nadivi | Philips, Viola Networks, and KenTech Ventures | General Partner | Current |
Name | Peter J. Fitzgerald | Michal Geva | Martin B Leon | Dani Goldsher | Netalie Nadivi |
---|---|---|---|---|---|
Work History | LR Group, and Deloitte | Philips, Viola Networks, and KenTech Ventures | |||
Title | Founder | Founder, Managing Partner | Founder | Chief Financial Officer | General Partner |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.